Friday, July 31, 2026

North Korean Drone Scandal: Graduate Student Faces Arrest for Espionage

A South Korean graduate student faces arrest for launching drones into North Korea, allegedly for economic gain from the drone industry.

Dialysis Unit Certification Not Just a Label but a “Survival Signal”… Mortality Risk Down 10%

A study reveals that certified dialysis centers in Asia significantly lower patient mortality rates, highlighting the importance of quality care.

Jang Dong-hyuk’s U.S. Meetings: Uncovering the Secrets Behind Korea-U.S. Alliance Discussions

Jang Dong-hyuk of the People Power Party discusses U.S. relations and intelligence leaks in a meeting with Deputy Ambassador Heller.

Tag: development

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

Verismo Therapeutics Welcomes FDA Approval Expert Dennis Williams: What This Means for CAR-T Cell Therapy

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

Discover the Legacy: Hanmi Group Unveils Monument Honoring Founder Lim Seong-ki

Hanmi Group honors founder Lim Seong-ki with a bronze sculpture, celebrating his legacy in pharmaceutical innovation and drug development.

Glass Substrate Rival? This New Ceramic Package Is Credit-Card Thin (0.008 in.) With Near-Zero Warping

Korea Ceramic Technology Institute develops ultra-thin ceramic semiconductor substrate, enhancing AI signal processing and efficiency.

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

South Korean Biotech Seeks Breakthrough in $Trillion-Scale Alzheimer’s Market

AriBio's AR1001 is a promising oral Alzheimer's drug aiming for global blockbuster status by 2027, focusing on convenience and safety.

How Ildong Bioscience is Revolutionizing Health Supplements at Vitafoods India 2026

Ildong Bioscience participated in the 2026 Vitafoods India expo, showcasing innovative health products and seeking partnerships in the healthcare sector.

Can Samjin Pharm Overcome Generic Drug Price Cuts With AI-Driven Drug Development?

Samjin Pharm shifts focus to R&D, moving away from generics to innovative drug development, amid government price cuts.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Unlocking Weight Loss: Hanmi Pharmaceutical’s Innovative H.O.P Project and the Game-Changing Epaglenatide

Hanmi Pharmaceutical is innovating obesity treatment with efpeglenatide and HM15275, focusing on tailored solutions for Korean patients.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

K-Beauty Boom: How Classys, Hugel, and Wontech are Expanding in Global Markets

The K-beauty industry is growing, leveraging strong manufacturing and R&D capabilities alongside the global spread of Hallyu.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.